Breakout for Covetrus (CVET) in the Charts?

: CVET | Covetrus Inc. News, Ratings, and Charts

CVET – An ascending triangle pattern has formed in the chart of Covetrus Inc. (CVET). A breakout could occur if the resistance level is broken. Read more to learn how to profit off this trade.

An ascending triangle pattern has formed in the chart of Covetrus Inc. (CVET).  If the resistance level is broken, a breakout could occur.

CVET is an animal-health technology and services company dedicated to supporting the companion, equine, and large-animal veterinary markets. The company’s services include supply chain services, software solutions, and prescription management.

The company, which recently finalized its exit from parent company Henry Schein, Inc. (HSIC), beat earnings and revenue last month, with EPS up 52.9% year over year, and revenue up 10.8% to $1.13 billion. CVET’s strategy of focusing on customer engagement has enabled it to drive growth higher than its pre-COVID rates, and scale its operations by significantly investing in pharmacy capacity and innovation.

As of the latest quarter, the company had $355 million in cash, up from $68 million in the same quarter last year. Its long-term debt of $1.1 billion is high, but its current ratio is healthy at 2.1. Sales are expected to grow 4.9% next year and revenue is expected to increase by 12.2% for 2021.

The company is trading at a low valuation, with a Price to Sales ratio of 0.7 and a Price to Book ratio of 2.5. The stock has shown strong medium and long-term momentum, but weak near-term performance.

Take a look at the 1-year chart of CVET below with the added notations:

  Chart of CVET provided by TradingView

While climbing a trendline of support (green), CVET has also formed an important level of resistance at $30 (red), thus creating an ascending triangle pattern. The stock just bounced off the trendline again and could make another run at the $30 level. At some point, either that level or the trendline support will break.

A long trade could be entered on a break above $30, with a protective stop placed under the point of entry.

Want to Discover More Great Trades?

I have explored virtually every flavor of technical analysis and chart pattern known to mankind. The sad fact is that the vast majority of them don’t work at all.

That is why I recently put together this special report to help investors focus on the only 5 chart patterns that matter…the ones that lead to the most timely and profitable stock trades. Click below to get your copy now!

5 WINNING Stock Chart Patterns

Have a good trading day!

Good luck!

Christian Tharp, CMT

@cmtstockcoach


CVET shares were trading at $27.16 per share on Monday morning, up $0.66 (+2.49%). Year-to-date, CVET has declined N/A%, versus a 16.44% rise in the benchmark S&P 500 index during the same period.


About the Author: Christian Tharp, CMT


Christian is an expert stock market coach at the Adam Mesh Trading Group who has mentored more than 4,000 traders and investors. He is a professional technical analyst that is a certified Chartered Market Technician (CMT), which is a designation awarded by the CMT Association. Christian is also the author of the daily online newsletter Todays Big Stock. More...


More Resources for the Stocks in this Article

TickerPOWR RatingIndustry RankRank in Industry
CVETGet RatingGet RatingGet Rating

Most Popular Stories on StockNews.com


:  |  News, Ratings, and Charts

A Case of Stock Market Whiplash

Just when the stock market (SPY) was inches away from a record high at 4,000 it got saddled with 6 days of downward pressure. Why did this happen? Is the pain over? What happens next? Read on below for answers …

:  |  News, Ratings, and Charts

Mimecast Secures Stock of the Week Honors

Almost every single stock in the cyber security group is obscenely overpriced. That’s because it is riding one of the hottest growth trends around. However, if you dig deep enough you will find a growing firm in the group that is also a surprisingly good value. That is why MIME is our Stock of the Week.

:  |  News, Ratings, and Charts

Stay Away From These 3 Overvalued EV Stocks

The bullish EV industry outlook has helped many start-ups, without resources or products to trade at sky-high valuations. However, they do not have any substantial technological backing or production capacity to compete with the well-established players. Arcimoto (FUV), Electrameccanica Vehicles (SOLO), and XL Fleet (XL) are three such stocks that are currently trading at extremely high valuations and may witness a significant pullback in the near term.

:  |  News, Ratings, and Charts

4 Healthcare Stocks to Buy and Hold for the Long Term

The healthcare sector in the United States is on the cusp of major growth. Factors such as positivity around the COVID-19 vaccine, an ageing U.S. population, and optimism over developments in the treatment of fatal diseases in general are brightening the prospects for healthcare stocks. Novartis AG (NVS), Abbott Laboratories (ABT), Merck & Company, Inc (MRK), and Eli Lilly and Company (LLY) are cases in point. They are top players in the healthcare space that investors could buy now and hold for the long term.

:  |  News, Ratings, and Charts

Stay Away From These 3 Overvalued EV Stocks

The bullish EV industry outlook has helped many start-ups, without resources or products to trade at sky-high valuations. However, they do not have any substantial technological backing or production capacity to compete with the well-established players. Arcimoto (FUV), Electrameccanica Vehicles (SOLO), and XL Fleet (XL) are three such stocks that are currently trading at extremely high valuations and may witness a significant pullback in the near term.

Read More Stories

More Covetrus Inc. (CVET) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All CVET News